Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers

Phase 1 Completed 24 enrolled Boehringer Ingelheim

RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the relative bioavailability of dabigatran with and without concomitant administration of diclofenac and the relative bioavailability of diclofenac with and without concomitant administration of dabigatran etexilate

Timeline

Start: 2006-05
Primary completion: 2006-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dabigatran etexilate	Unknown	150 mg	Oral
Subject	Diclofenac	Other / unclassified	50 mg	Oral

Indications

No indication recorded.